GSK buys rights to Hansoh Pharma antibody-drug conjugate

By

Sharecast News | 20 Dec, 2023

GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Last news

Sector movers: Defensives bounce back at month's end
Week ahead: US non-farm payrolls, ECB in the spotlight
London close: Stocks end up as investors mull US inflation reading
Directors deals: Hochschild Mining boss adds to holdings
US personal income and spending ease in April, core PCE prices slow